A cell-permeable benzoxazolo-sulfonamide compound that blocks human FBPase-1 enzymatic activity by competing at the AMP allosteric binding site (IC₅₀ = 3.4 µM; Ki = 1.1 µM); blocks glucose production in starved rat hepatoma cells (IC₅₀ = 6.6 µM).